Version 2.74


Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s.[PMID: 18568113] Amobarbital is a barbiturate that is used as a hypnotic and sedative. Physical effects include central nervous system depression and dependence when dosage levels are high. [PubChem: amobarbital] Source: Regenstrief LOINC

Basic Part Properties

Part Type
Component (Describes the core component or analyte measured)
Created On
Construct for LOINC Short Name

LOINC Terminology Service (API) using HL7® FHIR®

CodeSystem lookup$lookup?system=
ConceptMap translate$translate?system=

Language Variants

Tag Language Translation
zh-CN Chinese (China) 异戊巴比妥
Synonyms: C11H18N2O3
fr-CA French (Canada) Amobarbital
et-EE Estonian (Estonia) Amobarbitaal
es-ES Spanish (Spain) Amobarbital
it-IT Italian (Italy) Amobarbitale
tr-TR Turkish (Turkey) Amobarbital
ru-RU Russian (Russian Federation) Амобарбитал
nl-NL Dutch (Netherlands) amobarbital
fr-BE French (Belgium) Amobarbital